Guardant Health
GH
#1335
Rank
C$24.20 B
Marketcap
C$182.52
Share price
-2.20%
Change (1 day)
173.63%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of March 2026 : C$2.71 Billion

According to Guardant Health 's latest financial reports the company's total assets are C$2.71 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$2.75 B29.36%
2024-12-31C$2.13 B-10.03%
2023-12-31C$2.36 B8.46%
2022-12-31C$2.18 B-22.24%
2021-12-31C$2.80 B-3.01%
2020-12-31C$2.89 B130.42%
2019-12-31C$1.25 B57.11%
2018-12-31C$0.80 B85.58%
2017-12-31C$0.43 B175.24%
2016-12-31C$0.15 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
C$4.75 B 75.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C$3.70 B 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA